Exercise training in pulmonary hypertension: Improving performance but waiting for outcome

European Heart Journal

Volumn 37, Issue 1, 2016, Pages 45-48

  Galie, Nazzareno ^a   Manes, Alessandra ^b   Palazzini, Massimiliano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOREDUCTASE;

AEROBIC CAPACITY; ARTICLE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; ENDOTHELIAL DYSFUNCTION; ENDURANCE; ENZYME ACTIVITY; EXERCISE; HEALTH CARE QUALITY; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; META ANALYSIS (TOPIC); MUSCLE DISEASE; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 36; SKELETAL MUSCLE; SKELETAL MUSCLE DYSFUNCTION; EXERCISE TOLERANCE; KINESIOTHERAPY; TREATMENT OUTCOME;

EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; HYPERTENSION, PULMONARY; TREATMENT OUTCOME;

EID: 84960158567     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv440     Document Type: Article

References (20)

1. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D42-D50.
2. Galiè N, Humbert M, Vachiery J-L, Gibbs JS, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez-Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci-Cerinic M, McDonagh T, Pierard L, Trindade PT, Zompatori M, Hoeper M. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016;37: 67-124.
3. Galie N, Palazzini M, Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J 2010;31: 2080-2086.
4. Galie N, Corris P, Frost A, Girgis R, Granton J, Jing ZC, Klepetko W, McGoon M, McLaughlin VV, Preston RJ, Rubin LJ, Sandoval J, Seeger W, Keogh AM. Updated treatment algorithm of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D60-D72.
5. Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R, Uiker S, Halank M, Olsson K, Seeger W, Gall H, Rosenkranz S, Wilkens H, Mertens D, Seyfarth HJ, Opitz C, Ulrich S, Egenlauf B, Gruenig E. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: A prospective, randomized, controlled trial. Eur Heart J 2016;37:35-44.
6. Buys R, Avila A, Cornelissen V. Exercise training improves physical fitness in patients with pulmonary arterial hypertension: A systematic review and meta-analysis of controlled trials. BMC Pulm Med 2015;15:40.
7. Meyer FJ, Lossnitzer D, Kristen AV, Schoene AM, KublerW, Katus HA, Borst MM. Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 2005;25:125-130.
8. Kabitz HJ, Schwoerer A, Bremer HC, Sonntag F, Walterspacher S, Walker D, Schaefer V, Ehlken N, Staehler G, Halank M, Klose H, Ghofrani HA, Hoeper MM, Gruenig E, Windisch W. Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci (Lond) 2008;114:165-171.
9. Bauer R, Dehnert C, Schoene P, Filusch A, Bartsch P, Borst MM, Katus HA, Meyer FJ. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 2007;101:2366-2369.
10. de Man FS, Handoko ML, Groepenhoff H, van't Hul AJ, Abbink J, Koppers RJH, Grotjohan HP, Twisk JWR, Bogaard HJ, Boonstra A, Postmus PE, Westerhof N, Van Der Laarse WJ, Vonk-Noordegraaf A. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2009;34:669-675.
11. Maltais F, LeBlanc P, Simard C, Jobin J, Berube C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-447.
12. Ventura-Clapier R, Mettauer B, Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res 2007; 73:10-18.
13. Erbs S, Hollriegel R, Linke A, Beck EB, Adams V, Gielen S, Mobius-Winkler S, Sandri M, Krankel N, Hambrecht R, Schuler G. Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ Heart Fail 2010;3:486-494.
14. Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation 2007;115:3086-3094.
15. Kuehne T, Yilmaz S, Steendijk P, Moore P, Groenink M, Saaed M, Weber O, Higgins CB, Ewert P, Fleck E, Nagel E, Schulze-Neick I, Lange P. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004;110: 2010-2016.
16. Sarna S, Sahi T, Koskenvuo M, Kaprio J. Increased life expectancy of world class male athletes. Med Sci Sports Exerc 1993;25:237-244.
17. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA 2002;288: 1994-2000.
18. Fleming TR, Powers JH. Biomarkers and surrogate endpoints in clinical trials. Statist Med 2012;31:2973-2984.
19. Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Galie N, Gomez-Sanchez MA, Grimminger F, Grunig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T, Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn DA, Ghofrani HA. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation 2013;127: 1128-1138.
20. Handoko ML, de Man FS, Allaart CP, Paulus WJ, Westerhof N, Vonk-Noordegraaf A. Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart. Eur Resp Rev 2010; 19:72-82.